🧪 GLP-2 Tirzepatide 30mg: Metabolic Research Profile
GLP-2 Tirzepatide 30mg is a synthetic polypeptide precision-engineered for studies targeting the simultaneous activation of GIP and GLP-1 receptors. Researchers utilizing GLP-2 Tirzepatide 30mg focus on its unique chimeric structure, which incorporates a C-20 fatty diacid moiety at the lysine-20 position to enhance its bioactivity and resistance to enzymatic degradation in research settings.4
-
Dual Receptor Affinity: The GLP-2 Tirzepatide 30mg peptide is researched for its high affinity for both GIP and GLP-1 receptors, triggering intracellular cyclic adenosine monophosphate (cAMP) production.
-
Albumin Binding Stabilization: Featuring a C-20 fatty diacid modification, GLP-2 Tirzepatide 30mg facilitates high affinity with albumin, resulting in an extended biological half-life in research models.5
-
Insulin Signaling Pathways: Studies on GLP-2 Tirzepatide 30mg often involve evaluating its role in stimulating glucose-dependent insulin secretion in cellular analogs.
-
Energy Homeostasis: Laboratory evaluations of GLP-2 Tirzepatide 30mg explore its ability to modulate appetite centers in the hypothalamus and improve metabolic flexibility.6
🔬 Key Research Applications of GLP-2 Tirzepatide 30mg
This peptide is primarily used in laboratory models investigating:
-
🧬 Metabolic Homeostasis: Studies on GLP-2 Tirzepatide 30mg look at the synergistic effects of dual agonism on glucagon suppression and glucose metabolism.
-
🧠 Neuroprotective Dynamics: Research into GLP-2 Tirzepatide 30mg includes neurogenesis and the protection of neuronal structures from insulin-related oxidative stress.
-
🛡️ Hepatoprotective Research: Investigations into the biochemical properties of GLP-2 Tirzepatide 30mg focus on the stabilization of liver enzymes and visceral fatty tissue progression in animal models.
-
🫀 Vascular Integrity: Evaluation of GLP-2 Tirzepatide 30mg for endothelial function and its influence on cardiovascular signaling pathways.
✅ GLP-2 Tirzepatide 30mg Product Specifications
| Specification | Detail |
| Product Name | GLP-2 Tirzepatide 10mg |
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | 4813.5 g/mol |
| Concentration | 30 mg per vial |
| Sequence | 39-amino acid linear chimeric peptide |
| Appearance | White to off-white lyophilized powder |
| Format | Lyophilized powder for reconstitution |
| Solubility | Soluble in water or PBS (up to 5 mg/ml) |
❄️ Product Care & Handling Guidelines
Proper storage is required to maintain the molecular integrity of the GLP-2 Tirzepatide 30mg polypeptide.
-
Unreconstituted (Powder): Store GLP-2 Tirzepatide 30mg in a cool, dry environment. Long-term storage is optimal at -20°C to -80°C.
-
Reconstituted (Liquid): Refrigerate GLP-2 Tirzepatide 30mg at 2°C to 8°C; researchers typically use within 7 to 14 days for maximum stability.
-
Handling Note: Peptides like GLP-2 Tirzepatide 30mg are sensitive to mechanical stress. Use gentle swirling during reconstitution and avoid vigorous shaking to prevent denaturation.
📚 References & Resources
NCBI PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC11387164/
PubMed: https://pubmed.ncbi.nlm.nih.gov/36050763/
NCBI PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC10122586/
PubChem:https://pubchem.ncbi.nlm.nih.gov/compound/Tirzepatide
NCBI PubMed: https://pubmed.ncbi.nlm.nih.gov/41197390/
⚠️ Laboratory Research Use Only Notice
The GLP-2 Tirzepatide 30mg product is strictly intended for in vitro and non-clinical laboratory research purposes only. It is not for human consumption, veterinary diagnostic, or therapeutic use. Statements regarding the biochemical potential of GLP-2 Tirzepatide 30mg have not been evaluated by the Food and Drug Administration (FDA). Researchers must follow established laboratory safety protocols.
